Tuesday, August 25, 2026
SLS stock searches exploded 10,950% as retail discovered this heavily shorted biotech ahead of its Phase 3 cancer trial catalyst, while macro recession anxiety collapsed 89% to 3-month lows, creating extreme complacency vulnerability. Wendy's squeeze searches hit 63,450% and the SPCX SpaceX confusion persists, but the SLS biotech narrative represents today's most significant new signal with 33% short interest and binary event risk.
Ongoing Stories(3)
Wendy's Short Squeeze
Still TrendingSearch interest for 'Wendy's short squeeze' hit +63,450% breakout, with price reaching $8.84 (+22% over 3 months). The squeeze narrative continues to drive retail attention.
See previous coverageSPCX SpaceX Confusion
Still TrendingSearch confusion persists with 'spcx stock' +76,750% breakout despite repeated coverage. Price remains weak at $135 (-16% over 3 months).
See previous coverageSandisk AI Memory Volatility
Winding DownSearch interest remains elevated (+3,150%) but price action has deteriorated (-6% over 3 months, -36% from highs). Retail attention may be fading as volatility fails to reward holders.
See previous coverageVisualizations(4)
The Short Squeeze Race: SLS vs WEN vs SPCX vs SNDK (3-Month Performance)
SLS dominates with +76.5% gains driven by biotech trial catalysts and 33% short interest, while Wendy's delivers steady +22.3% squeeze performance. SPCX continues its decline (-16.1%) despite persistent retail confusion, and Sandisk (-6.1%) shows AI memory volatility failing to translate to sustained gains.
Macro Sentiment: The Recession Anxiety Collapse
Recession 2026 searches collapsed 89% from July highs (11 to 1), while AI stock interest declined 89% from peak (82 to 9). Semiconductor interest similarly evaporated (28 to 3). This represents extreme macro complacency - retail is no longer hedging downside risk, creating vulnerability to surprise shocks.
Price Action: SLS Biotech Momentum vs Wendy's Squeeze Stealth
SLS surged from $8.12 to $14.33 (+76.5%) on cancer vaccine spillover from Moderna/Merck news and anticipation of REGAL trial 80th event. Wendy's climbed steadily from $7.23 to $8.84 (+22.3%) with lower volatility. SLS shows higher risk-reward with 52-week range of $1.39-$15.88.
Today's Top Search Breakouts: SLS Arrives
Wendy's short squeeze queries hit +63,450% breakout while SLS stock searches exploded +10,950%. SPCX continues its confusion-driven search spikes with +78,800% for 'spcx stock price'. These represent the four most significant retail attention signals in today's market.